The Ozempic diabetes dilemma - podcast episode cover

The Ozempic diabetes dilemma

Feb 12, 202544 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Ozempic is the hot drug for weight loss, but its original purpose was to help diabetics – putting its creator in a bit of a bind. Wired contributor Virginia Heffernan joins host Krys Boyd to discuss how Danish drugmaker Novo Nordisk is stretched thin as demand for the drug skyrockets – and how President Trump’s designs on Greenland might actually affect supply. Her article is “The King of Ozempic Is Scared as Hell.”

Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
The Ozempic diabetes dilemma | KERA's Think podcast - Listen or read transcript on Metacast